関連する実験動画
Updated: Sep 8, 2025

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.0K
アトピー性皮膚炎連続体:一般的な疾患の最新のパラダイムと新しい多目的治療法
Journal of drugs in dermatology : JDD
|September 5, 2025
まとめ
アトピー性皮膚炎 (AD) の4つの主要な要因である炎症,感染,,およびキセロシスを有効に標的としています. この多目的アプローチは この慢性的な皮膚疾患の管理に 有望な結果を示しています
科学分野:
- 皮膚科
- 免疫学
- 微生物学
背景:
- アトピー性皮膚炎 (AD) は,複雑なトリガーを伴う慢性炎症性皮膚疾患である.
- 現在の治療法では全てのAD症状が完全には対処できないため,多標的治療が必要である.
研究 の 目的:
- アルツハイマー病のトリガーと病理的表象を 検討する.
- 局所用ザバラフィン・ヒドロゲルの有効性を評価する臨床試験
主な方法:
- 専門家パネルは文献の構造的なレビューを行った.
- ADのトリガーと連続体に関するコンセンサス声明が作成されました.
- 軽度から中等度のAD患者における局所用ザバラフィン・ヒドロゲルの第2期臨床試験
主要な成果:
- ADの4つの相互依存の病理的表現:炎症,コロニゼーション/ディスバイオシス/感染,キセロシス,および.
- 局所用ザバラフィン・ヒドロゲルは,炎症,Staphylococcus aureusのコロニー化/感染,不活性化,,およびキセロシスを軽減しました.
- ザバラフィン・ヒドロゲルは副作用がほとんどなかった.
結論:
- アトピー性皮膚炎は,その連続性を扱う多目的の治療戦略を必要とします.
- 相互に関連した病理的過程をターゲットにすることで,持続的なAD制御の可能性を示しています.
関連する概念動画
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
446
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
446
Asthma: Pathogenesis and Management
573
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
573
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma-IV: Nursing Management
3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.3K
Antiasthma Drugs: Leukotriene Modifiers
453
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
453

